Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Roberto Galea Added: 1 year ago
EHRA 2025 - Three-year findings comparing the Amplatzer Amulet (St. Jude Medical-Abbott) and Watchman/FLX (Boston Scientific) systems for left atrial appendage (LAA) occlusion show a trend towards a lower ischemic risk in the Amulet group compared with the Watchman/FLX group in terms of a composite of CV death, stroke, transient ischemic attack or systemic embolism.Dr Roberto Galea (Inselspital,… View more
Author(s): Walid Saliba Added: 1 year ago
AF Symposium 25 - Left atrial appendage (LAA) closure using the WATCHMAN FLX device (Boston Scientific) showed lower risk of bleeding and non-inferiority in efficacy endpoints to oral anticoagulation in patients who have received or are planning to receive AF ablation.Dr Walid Saliba (Cleveland Clinic, OH, US) joins us onsite at AF Symposium 25 to discuss the findings from the concomitant and… View more
Author(s): Saibal Kar , Harriette Van Spall Added: 2 months ago
ACC.26 – Late-breaker host Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Saibal Kar, MD (Los Robles Regional Medical Center, US) to discuss CHAMPION‑AF (NCT04394546), a global randomized trial comparing the WATCHMAN FLX left atrial appendage closure device with non–vitamin K oral anticoagulants in patients with non‑valvular atrial fibrillation at elevated stroke risk… View more
Author(s): Luigi Di Biase Added: 1 year ago
Stay up to date with our video collection covering late-breaking data from AF Symposium 2025 in Boston. Don't miss our short, accessibleExpert Interviews and Highlights of the most pertinent trials. View more
Author(s): Dhanunjaya Lakkireddy Added: 1 year ago
AHA Conference 2024 - Five-Year safety and efficacy follow-up outcomes investigating the non-inferiority of the AMPLATZER Amulet device (Abbott Medical Devices) against the commercially available WATCHMAN (Boston Scientific) device.Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute - HCA Midwest, KS, US) joins us onsite at AHA Conference to discuss the findings from Amulet IDE … View more
Start date: May 06, 2025
Join us for the Transform AF - Concomitant Ablate and Close Workflow Series, an advanced educational series tailored for electrophysiologists eager to deepen their understanding of concomitant FARAPULSE™ and WATCHMAN FLX™ Pro workflows. This comprehensive series is designed specifically for electrophysiologists seeking to enhance their expertise in concomitant procedural workflows. Esteemed… View more
Author(s): Added: 1 month ago
Dr Amr Nawar (Sultan Qaboos University Hospital, Muscat, OM) walks through a concomitant pulmonary vein isolation (PVI) and left atrial appendage (LAA) closure procedure in a single 90-minute session — treating the arrhythmia and addressing embolic risk simultaneously.The case centres on a 70-year-old male with atrial fibrillation and a history of two transient ischaemic attacks. Dr Nawar details… View more
Author(s): Devi Nair , Vivek Reddy Added: 2 months ago
ACC.26 - At ACC.26 in New Orleans, Dr Devi Nair (Arkansas, US) and Dr Vivek Reddy (New York, US) dissect the late-breaking CHAMPION‑AF trial, a large randomized comparison of first-line left atrial appendage closure with WATCHMAN FLX versus continued NOAC therapy in patients with non-valvular AF who can tolerate anticoagulation. They review the trial design, post‑implant antithrombotic and… View more
Research Area(s) / Expertise:
Dr Pugazhendhi Vijayaraman obtained his medical degree from Madurai Medical College and completed his residency at Jacobi Medical Center. He completed his fellowships in cardiovascular diseases and clinical cardiac electrophysiology at the Albert Einstein College of Medicine of Yeshiva University, Montefiore Medical Center. Dr Vijayaraman specialises in cardiac electrophysiology, cardiac… View more
Job title: Cardiologist
Dr Robert Cubeddu is President at NCH Rooney Heart Institute, Florida, US and is board-certified in Cardiovascular Medicine and Interventional Cardiology, with advanced sub-specialty training in Structural Heart Disease.Dr Cubeddu founded a comprehensive, high-volume premier regional centre of referral in Structural Heart including percutaneous transcatheter valves therapies (TAVR, TMVR,… View more